Functioning Disturbance in Chronic Back Pain: Altered Muscle Metabolism

The main objective of this study is to investigate the muscle metabolism in individuals with chronic non-specific low back pain (CNSLBP) to enhance our understanding of chronic back pain.

Study Overview

• Status: Unknown
• Conditions: Chronic Non-specific Low Back Pian

• Study Type: Observational
• Enrollment (Anticipated): 6

Contacts and Locations

• Study Contact: Name: Aage Indahl, PhD, MD; Phone Number: (+47)33134045; Email: aage.indahl@siv.no
• Study Contact Backup: Name: Vegard Pihl Moen, PT, MSc; Phone Number: (+47)33134097; Email: vegard.pihl.moen@siv.no

Study Locations

• Norway
  • Stavern, Norway, 3290
    • Recruiting
    • Kysthospitalet, Vestfold Hospital Trust
    • Contact: Aage Indahl, MD, PhD; Phone Number: +4791765888; Email: aage.indahl@siv.no
    • Contact: Vegar Phil Moen, MS; Phone Number: +4792438242; Email: Vegar.Phil.Moen@siv.no

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 30 years to 50 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Persons referred to Hospital of rehabilitation due to chronic non-specific low back pain

Description

The NSCBP group:

• At least 6 patients will be included in this study.
• All patients referred to Vestfold Hospital Trust, Kysthospitalet, diagnosed with chronic NSCBP >3 months duration will be invited to participate in the study. The invitation will be in a written form.

Exclusion Criteria:

• anamnesis of medical or drug abuse,
• surgery on the musculoskeletal system of the trunk,
• known congenital malformation of the spine or scoliosis,
• body mass index > 27 kg/m2,
• systemic-neurological-degenerative disease,
• history of stroke,
• psychiatric disorder,
• pregnancy and abnormal blood pressure. The subjects will be asked not to use any medications except for paracetamol preparations one week before examination and instructed not to perform any back-straining exercise for 48 h prior to the study, except for ordinary daily working and/or leisure activities.

Study Plan

How is the study designed?

Design Details

• Observational Models: Case-Only
• Time Perspectives: Cross-Sectional

Collaborators and Investigators

• Sponsor: Oslo University Hospital
• Collaborators: The Research Council of Norway

Study record dates

Study Major Dates

• Study Start: May 1, 2012
• Primary Completion (Anticipated): June 1, 2013
• Study Completion (Anticipated): December 1, 2013

Study Registration Dates

• First Submitted: May 4, 2012
• First Submitted That Met QC Criteria: May 7, 2012
• First Posted (Estimate): May 8, 2012

Study Record Updates

• Last Update Posted (Estimate): May 8, 2012
• Last Update Submitted That Met QC Criteria: May 7, 2012
• Last Verified: May 1, 2012

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Back Pain
• Other Study ID Numbers: 182006/V50; 08/5253 Personvernombudet RRHF

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No